Bio Path Holdings Inc (BPTH)

[Runninonempty]

SJ, I think the burn rate is not quite as high as you suggest. Also if we have twice as many shares outstanding when the drug gets approved, that would not be a bad thing would it? It should justify a 2 B market cap but because of PN let’s just assume it is 1 B. Even with 22 million shares outstanding, that is a $45 ($4.50 pre-split) stock price which seems pretty good from where we are sitting at the present. My point is dilution is not horrible if it gets BPTH the money to prove the technology, but then again it is PN at the helm:(